Regulatory News
Wednesday, April 20, 2016
BRIEF-Medicinova announces interim data from clinical trial of MN-166 (ibudilast) in ALS
* Announces interim data from clinical trial of MN-166
(ibudilast) in ALS presented at the American Academy of
Neurology (AAN) 68th annual meeting in Vancouver, Canada
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment